Fintel reports that on November 20, 2025, Cantor Fitzgerald reiterated coverage of Palo Alto Networks (NasdaqGS:PANW) with a ...

Fintel reports that on November 20, 2025, Cantor Fitzgerald initiated coverage of Lexeo Therapeutics (NasdaqGM:LXEO) with a ...

As Meta Platforms shifts focus and rides a bullish trend, investors should formulate a strategy for all likely outcomes. 24/7 ...

Celebrate Hanukkah and the release of klezmer clarinetist Michael Winograd’s new album “TANZ! Live in NYC,” at Brooklyn’s ...

Archer acquires Hawthorne Airport near LAX for $126 million to establish a strategic air taxi network hub and an AI ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Caesars Entertainment executives were apologetic about embarrassing the state by not catching an illegal bookmaker when he ...

Cantor Fitzgerald analyst Jay Kornreich maintained a Buy rating on NETSTREIT today and set a price target of $21.00. The company’s shares closed today at $18.62. Take advantage of TipRanks Premium at ...

There were a couple of noteworthy caveats. The unemployment rate increased to a four-year peak of 4.4 percent, suggesting ...

Stratasys’ third quarter results met Wall Street’s revenue expectations, but the market reacted negatively as year-over-year ...

Inhibikase Therapeutics Inc (NASDAQ:IKT) stock fell 2.6% in after-hours trading Thursday following the company’s announcement of a new underwritten public offering of common stock and pre-funded ...

Heightened volatility and mixed investor sentiment can be seen across the cryptocurrency market, as digital assets decline ...